Home Newsfeeds CNBC Halftime Report Final Trades: Seagate Technology, Dollar General & Progressive

CNBC Halftime Report Final Trades: Seagate Technology, Dollar General & Progressive

– CNBC

byBenzinga Newsdesk

October 12, 2022

1 minute read

– CNBC

Western Alliance Shares Surge On Earnings Beat, Recent Deposit Strength: The Details

By Adam Eckert

April 19, 9:21 AM

Western Alliance Bancorp (NYSE: WAL) shares are trading higher Wednesday after the company reported first-quarter results and said deposits stabilized late

WAL

News

Earlier Reported, ‘Intel Planning Price Hike Across All “Core” CPUs As A Part Of Restructuring Policy; The Price Hikes Ranged Anywhere From Single-Digit And Up To 20%’ – WCCFtech

By Happy Mohamed

July 25, 3:24 PM

https://wccftech.com/intel-planning-price-hike-across-all-core-cpus-as-a-part-of-restructuring-policy/ Intel will reportedly increase the pricing of its current CPU lineup to squeeze out revenue for fab

INTC

Why DexCom Shares Are Trading Higher Today

By Lekha Gupta

July 28, 10:01 AM

DexCom Inc (NASDAQ: DXCM) shares are trading higher after the company reported

DXCM

Ascendis Pharma Introduces Vision 2030; Preliminary Unaudited December 31, 2023 Cash, Cash Equivalents, And Marketable Securities Of ~€400M; Full Year 2024 SKYTROFA Revenue Expected To Be €320M-€340M

By Benzinga Newsdesk

January 7, 9:16 PM

Strategic roadmap to achieve blockbuster status for multiple products and expandthe Company's engine for future innovation COPENHAGEN, Denmark, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND)

ASND

CNBC Halftime Report Final Trades: Seagate Technology, Dollar General & Progressive

Related Posts

Western Alliance Shares Surge On Earnings Beat, Recent Deposit Strength: The Details

Earlier Reported, ‘Intel Planning Price Hike Across All “Core” CPUs As A Part Of Restructuring Policy; The Price Hikes Ranged Anywhere From Single-Digit And Up To 20%’ – WCCFtech

Why DexCom Shares Are Trading Higher Today

Ascendis Pharma Introduces Vision 2030; Preliminary Unaudited December 31, 2023 Cash, Cash Equivalents, And Marketable Securities Of ~€400M; Full Year 2024 SKYTROFA Revenue Expected To Be €320M-€340M